pulmonary nodules
Conditions
Interventions
Gold Standard:The histopathological classification in this study was based on 2015 WHO Histological Classification of Lung Cancer, while the staging of cancer was based on the Eighth Edition of the AJ
Index test:Bai-DX & MDA TEST
Sponsors
Zhongshan Hospital, Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Subjects who were identified with <= 30mm single or multiple pulmonary nodule by CT/LDCT in the past 6 months. 2. Subjects who were at least 18 years old. 3. Subjects who planned to receive pulmonary nodule non-surgical biopsy or surgical removal and did pathological examinations. 4. Subjects who volunteered for this clinical study and had given written informed consent, prior to treatment.
Exclusion criteria
Exclusion criteria: 1. Subjects who were pregnant, trying to get pregnant or nursing. 2. Subjects who had severe cardiac, pulmonary, hepatic dysfunction or mental disorders. 3. Subjects who received clinical interventions in lung cancer, such as surgery, radiotherapy, chemotherapy, targeted therapy, immunotherapy etc. 4. Subjects whose samples could not meet the pathological examination requirements of investigational center. 5. Subjects who were known to have a history of malignant tumors in the past 5 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CAC;SEN, SPE, ACC, AUC of ROC, +LR, -LR; | — |
Countries
China
Contacts
Public ContactChunxue Bai
Zhongshan Hospital, Fudan University
Outcome results
None listed